Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The managing director of a major pharmaceutical site in Germany has accused the country's politicians of pursuing the wrong ...

The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...

Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...

Amid growing anxiety over tariffs, one medical center has warned its suppliers that any sudden price hikes attributed to the ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines, the latest effort by ...

As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...

Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.